[go: up one dir, main page]

Blatt et al., 1974 - Google Patents

Thrombogenic materials in prothrombin complex concentrates

Blatt et al., 1974

Document ID
16456237806611246886
Author
Blatt P
Lundblad R
Kingdon H
McLEAN G
Roberts H
Publication year
Publication venue
Annals of Internal Medicine

External Links

Snippet

Prothrombin complex concentrates are now available for use for treatment of bleeding complications associated with deficiencies of factors II, VII, IX, or X. The purpose of this report is to describe a patient who died immediately after the infusion of such a concentrate …
Continue reading at www.acpjournals.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Similar Documents

Publication Publication Date Title
Blatt et al. Thrombogenic materials in prothrombin complex concentrates
JP2766986B2 (en) Pharmaceutical compositions for preventing thrombotic occlusion or embolism of arteries
McKay et al. Alterations in the blood coagulation system induced by bacterial endotoxin: I. In vivo (generalized Shwartzman reaction)
Zivelin et al. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors.
Innerfield et al. Intravenous trypsin: its anticoagulant, fibrinolytic and thrombolytic effects
JP3038006B2 (en) Compositions and methods for treating or preventing sepsis or septic shock
Breen et al. Prothrombin concentrates in treatment of Christmas disease and allied disorders
Deykin et al. Hepatic removal of activated factor X by the perfused rabbit liver
US4479938A (en) Therapeutic composition containing factor VIIa
US4287180A (en) Method for treating blood clotting factor inhibitors
Dosekun et al. Ancrod in systemic lupus erythematosus with thrombosis: clinical and fibrinolysis effects
Vinazzer Clinical use of antithrombin III concentrates
Gitel et al. The antithrombotic effects of warfarin and heparin following infusions of tissue thromboplastin in rabbits: clinical implications
Rapaport et al. Consumption of serum factors and prothrombin during intravascular clotting in rabbits
CA1337046C (en) Thrombolytic agent
JPH02504587A (en) Method for producing a fraction rich in factor 7a and its use as a medicine
CA1176563A (en) Therapeutic compositions and methods for manufacture and use
Dubber et al. In vitro and in vivo studies with Trasylol, an anticoagulant and a fibrinolytic inhibitor
ALEXANDER et al. Proteolysis, fibrinolysis, and coagulation: Significance in thrombolytic therapy
Gilchrist et al. Evaluation of a new concentrate for the treatment of factor IX deficiency
Guest et al. A study of the antifibrinolysin activity in human plasmas during pathological states
US5055295A (en) Lysis of fibrin blood clots with urokinase and pro-urokinase
Cliffton Early experience with fibrinolysin
PORTS et al. Intravascular coagulation in fresh-water submersion: Report of three cases
US4459288A (en) Therapeutic blood clotting factor compositions and their use